HEXCARE Stock Overview
Hextar Healthcare Berhad, an investment holding company, manufactures, trades, and sells In-Vitro Diagnostic (IVD) medical devices in Malaysia and Europe.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Hextar Healthcare Berhad Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | RM0.20 |
52 Week High | RM0.35 |
52 Week Low | RM0.20 |
Beta | 0.59 |
1 Month Change | -4.65% |
3 Month Change | -29.31% |
1 Year Change | -31.67% |
3 Year Change | -79.90% |
5 Year Change | 38.20% |
Change since IPO | -66.48% |
Recent News & Updates
Recent updates
Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking
Dec 18The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing
Aug 30We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger
May 27Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)
Feb 26Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?
Nov 17If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late
May 11What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?
Apr 12Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 02Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today
Feb 09Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive
Jan 22How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?
Jan 04If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today
Dec 17Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?
Dec 02Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?
Nov 18What Does Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) CEO Pay Reveal?
Jul 14Shareholder Returns
HEXCARE | MY Household Products | MY Market | |
---|---|---|---|
7D | -2.4% | -1.1% | 0.4% |
1Y | -31.7% | -14.9% | 10.2% |
Return vs Industry: HEXCARE underperformed the MY Household Products industry which returned -14.9% over the past year.
Return vs Market: HEXCARE underperformed the MY Market which returned 10.2% over the past year.
Price Volatility
HEXCARE volatility | |
---|---|
HEXCARE Average Weekly Movement | 5.3% |
Household Products Industry Average Movement | 5.3% |
Market Average Movement | 5.2% |
10% most volatile stocks in MY Market | 11.6% |
10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: HEXCARE's share price has been volatile over the past 3 months.
Volatility Over Time: HEXCARE's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 775 | Chin Khoo | https://www.rubberex.com.my |
Hextar Healthcare Berhad, an investment holding company, manufactures, trades, and sells In-Vitro Diagnostic (IVD) medical devices in Malaysia and Europe. It operates through Gloves Operation and Medical Devices Operation segments. The company offers natural rubber, synthetic rubber, and nitrile disposable gloves for household, industrial, and professional applications.
Hextar Healthcare Berhad Fundamentals Summary
HEXCARE fundamental statistics | |
---|---|
Market cap | RM205.39m |
Earnings (TTM) | -RM66.12m |
Revenue (TTM) | RM155.09m |
1.3x
P/S Ratio-3.1x
P/E RatioIs HEXCARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HEXCARE income statement (TTM) | |
---|---|
Revenue | RM155.09m |
Cost of Revenue | RM164.29m |
Gross Profit | -RM9.20m |
Other Expenses | RM56.92m |
Earnings | -RM66.12m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.066 |
Gross Margin | -5.93% |
Net Profit Margin | -42.63% |
Debt/Equity Ratio | 0.2% |
How did HEXCARE perform over the long term?
See historical performance and comparison